Laboratory Products
Congenital Assay Panel Launched to the UK Market
Dec 10 2007
The Toxoplasma IgG assay has now been launched in the UK with IgM and avidity assays to follow. Rubella and CMV IgG and IgM assays are already available and CMV avidity is due for launch soon.
While other avidity assays remove low avidity antibodies by washing with chaotropic reagents, the new ARCHITECT AVIcomp technology selectively removes the high avidity antibodies and directly detects low avidity antibodies for improved diagnosis of acute or recurrent infection.
Low avidity assays are important for confirming primary infections while high avidity assays are used to detect non-primary (re-infection or reactivation of previous infection).
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark